JADPRO | Volume 5, Supplement 1 (May/Jun 2014)

Collaborative Practice Enhances Supportive Care in Cancer: Chemotherapy-Induced Nausea and Vomiting

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

Faculty

Rita Wickham, PhD, RN, AOCN®, Rush University College of Nursing (Adjunct Faculty)

Sally Barbour, PharmD, BCOP, CPP, Duke University Medical Center

Teresa Scardino, RPA-C, MPAS, Memorial Sloan Kettering Cancer Center

Continuing education credit is provided through the Meniscus Educational Institute, a triple accredited provider for CME/CE/CEU credits and contact hours, upon successful completion of the supplement and evaluation.

Supported by an unrestricted educational grant from Heron Therapeutics (formerly AP Pharma)

Continuing Education

Continuing Education Information

Editorial

Collaborative Practice Enhances Supportive Care in Cancer: Chemotherapy-Induced Nausea and Vomiting

Review Article

Risks for Chemotherapy-Induced Nausea and Vomiting: Capturing Relevant Data

Abstract Much of the success achieved in managing the side effects of chemotherapy-induced nausea and vomiting (CINV) centers on the evolving knowledge base regarding the physiology of vomiting. Increasing awareness of multiple afferent...

Review Article

Actualizing Standards of Care for Chemotherapy-Induced Nausea and Vomiting

Abstract Despite the development of newer antiemetics such as serotonin (5-HT3) and neurokinin-1 (NK-1) receptor antagonists, prevention of chemotherapy-induced nausea and vomiting (CINV) still presents a challenge to many patients and...

Review Article

Managing Chemotherapy-Induced Nausea and Vomiting: Past, Present, and Future

Abstract Although current antiemetic agents, either singularly or in combination, have had substantial positive effects on controlling chemotherapy-induced nausea and vomiting (CINV), there are still concerns regarding how well advanced...

Grand Rounds